










<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://52.214.119.220/wiki/skins/common/feed.css?97"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>AChE bivalent inhibitors - Revision history</title>
		<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;action=history</link>
		<description>Revision history for this page on the wiki</description>
		<language>en</language>
		<generator>MediaWiki 1.11.2</generator>
		<lastBuildDate>Fri, 10 Apr 2026 02:44:41 GMT</lastBuildDate>
		<item>
			<title>Alexander Berchansky: Redirecting to AChE inhibitors and substrates</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=2381823&amp;oldid=prev</link>
			<description>&lt;p&gt;Redirecting to &lt;a href=&quot;/wiki/index.php/AChE_inhibitors_and_substrates&quot; title=&quot;AChE inhibitors and substrates&quot;&gt;AChE inhibitors and substrates&lt;/a&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 10:13, 8 March 2015&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==PART I. Tacrine- and hupyridone-containing compounds==&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;#&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;REDIRECT &lt;/ins&gt;[[AChE inhibitors and substrates]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''This page is a continuation of the pages [[AChE inhibitors and substrates]], [[AChE inhibitors and substrates (Part II)]], and [[AChE inhibitors and substrates (Part III)]].'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;StructureSection load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' &amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The &amp;lt;scene name='1zgb/Act_site/3'&amp;gt;active site&amp;lt;/scene&amp;gt; of ''Tc''AChE consists of two binding subsites. First of them is the &amp;quot;catalytic anionic site&amp;quot; (CAS), which involves mentioned above [http://en.wikipedia.org/wiki/Catalytic_triad catalytic triad] &amp;lt;scene name='1zgb/Act_site/8'&amp;gt;Ser200, His440, and Glu327&amp;lt;/scene&amp;gt; &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(colored orange)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and the [http://en.wikipedia.org/wiki/Conserved_sequence&lt;/del&gt;#&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Conserved_protein_sequences_and_Structures conserved residues] &amp;lt;scene name='1zgb/Act_site/5'&amp;gt;Trp84&amp;lt;/scene&amp;gt; and &amp;lt;scene name='1zgb/Act_site/10'&amp;gt;Phe330&amp;lt;/scene&amp;gt; also participating in ligands recognition. Another conserved residue &amp;lt;scene name='1zgb/Act_site/11'&amp;gt;Trp279&amp;lt;/scene&amp;gt; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(colored cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; is situated at the second binding subsite, termed the &amp;quot;peripheral anionic site&amp;quot; (PAS), ~14 Å from CAS. Therefore, the ligands that will be able to interact with both these subsites, will be more potent [http://en.wikipedia.org/wiki/Acetylcholinesterase_inhibitor AChE inhibitors] in comparison to compounds interacting only with CAS. One of the ways to produce such ligands is to introduce two active substances into one compound. If it is spatially necessary these subunits could be divided by alkyl linker with suitable length.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt; &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;====(''RS'')-(±)-tacrine-(10)-hupyridone====&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;According to the strategy of the use of a bivalent ligand, the &amp;lt;scene name='1zgb/Comp/7'&amp;gt;inhibitor&amp;lt;/scene&amp;gt; '''(''RS'')-(±)-tacrine-(10)-hupyridone''' ((R)-3 or (S)-3) was designed and synthesized. It consists of mentioned in the page '&lt;/del&gt;[[AChE inhibitors and substrates&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;]]' &amp;lt;scene name='1zgb/Comp/8'&amp;gt;tacrine&amp;lt;/scene&amp;gt; &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(colored magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, 10-carbon &amp;lt;scene name='1zgb/Comp/9'&amp;gt;linker&amp;lt;/scene&amp;gt; &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt;(yellow)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, and &amp;lt;scene name='1zgb/Comp/10'&amp;gt;hupyridone&amp;lt;/scene&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;(red)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The tacrine moiety of this inhibitor binds at the CAS, the linker spans the &amp;lt;scene name='1zgb/Act_site/12'&amp;gt;active-site&amp;lt;/scene&amp;gt; gorge, and the hupyridone moiety binds at the PAS.    &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with [http://en.wikipedia.org/wiki/Tacrine tacrine] are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the [http://en.wikipedia.org/wiki/Aromaticity aromatic] residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å).&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The &amp;lt;scene name='1zgc/Al/5'&amp;gt;overlap&amp;lt;/scene&amp;gt; of &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 (cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[1zgc]]) bound to the ''Tc''AChE active site in the orthorhombic forms is shown. &amp;lt;scene name='1zgc/Zgc_h22/2'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a (magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3 (orange, orthorhombic ''Tc''AChE)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; demonstrates the similar mode of binding of the hupyridone unit at the PAS. The residues Trp279 (top) and Trp84 (bottom) represent the PAS and the CAS, respectively &amp;lt;ref name=&amp;quot;Haviv&amp;quot;&amp;gt;PMID:16076210&amp;lt;/ref&amp;gt;.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;{{Clear}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;====Bis-hupyridone====&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The comparison of the (R)-3/''Tc''AChE ([[1zgb]]) and bis-hupyridone/''Tc''AChE complexes ([[1h22]] and [[1h23]]) at the &amp;lt;scene name='1zgb/Align2/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. &amp;lt;scene name='1zgb/Align2/8'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(''R'')-tacrine-(10)-hupyridone ((R)-3, cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(12)-hupyridone ('''(S,S)-(-)-4b''', orange, ''i.e.'' 12-carbon-tether-linked hupyridone dimer)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(10)-hupyridone ('''(S,S)-(-)-4a''', plum)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; complexes demonstrates the binding mode of the hupyridone moiety. &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;TcAChE residues of symmetry-related molecule are shown in magenta.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; X-ray structures of ''Tc''AChE complexed with these 10- and 12-carbon-tether-linked 2 &amp;lt;scene name='1zgb/Align2/9'&amp;gt;dimers&amp;lt;/scene&amp;gt; &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; show one subunit bound at the &amp;lt;scene name='1zgb/Align2/10'&amp;gt;CAS&amp;lt;/scene&amp;gt;, the linker spanning the gorge, and the other subunit bound at the &amp;lt;scene name='1zgb/Align2/11'&amp;gt;PAS&amp;lt;/scene&amp;gt;. &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;There are two &amp;lt;scene name='1zgb/Align2/12'&amp;gt;hydrogen bonds&amp;lt;/scene&amp;gt; connecting the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;O&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;Lys11&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='blue'&amp;gt;&amp;lt;b&amp;gt;Nζ&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='blue'&amp;gt;&amp;lt;b&amp;gt;N&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;Gln185&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Oε1&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; of a &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;symmetry-related molecule&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE complex. &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; Another hydrogen bond connects the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;O&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to a water molecule, which is bound to Ser286 N. Similarly, the hupyridone-PAS unit of both &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; forms direct and an indirect hydrogen bonds with the protein backbone in the PAS region &amp;lt;ref name=&amp;quot;Haviv&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;Wong&amp;quot;&amp;gt;PMID:12517147&amp;lt;/ref&amp;gt;. &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;{{Clear}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;====Bis(''n'')-tacrine derivatives====&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; are bis(''n'')-tacrine derivatives with n=5 and 7 (number of carbons in the linkers), respectively. These compounds are more potent and selective AChE inhibitors than tacrine alone. The binding of the tacrine moiety of &amp;lt;scene name='2cmf/Comparison/2'&amp;gt;2d&amp;lt;/scene&amp;gt; at the ''Tc''AChE catalytic anionic site (CAS) is similar to that of &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;tacrine &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; in the tacrine/''Tc''AChE complex ([[1acj]]). The second tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; interacts with the peripheral anionic site (PAS) near Trp279. The interaction of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS causes an increase of the &amp;lt;scene name='2cmf/Comparison/3'&amp;gt;distance&amp;lt;/scene&amp;gt; between Ser200 Oγ and H440 Nε2 atoms, and, therefore, disruption of the catalytic triad (Ser200, H220, E327) as seen in the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The binding of 2d results in &amp;lt;scene name='2cmf/Comparison/4'&amp;gt;major structural changes&amp;lt;/scene&amp;gt; in the Val281-Ser291 loop  changing the surface of the active-site gorge from its   &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native conformation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The tacrine moiety of the compound &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;'''2f''' (heptylene-linked bis-tacrine&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS, [[2ckm]])  adopts similar &amp;lt;scene name='2cmf/Comparison/5'&amp;gt;conformation&amp;lt;/scene&amp;gt; as tacrine in the tacrine/''Tc''AChE complex and the tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS. The second tacrine moiety of the &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  interacts with PAS near the Trp279, like &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The &amp;lt;scene name='2cmf/Comparison/6'&amp;gt;binding&amp;lt;/scene&amp;gt; of  &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; does not cause significant structural changes in &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;''Tc''AChE&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; from its &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native  structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;.  &amp;lt;scene name='2cmf/Overlap/7'&amp;gt;Comparison&amp;lt;/scene&amp;gt; of the structures of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE  and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE reveals different contacts between the tacrine moieties of these compounds at the PAS and  ''Tc''AChE. There are two additional structures of tacrine-containing ''Tc''AChE complexes: compounds &amp;lt;scene name='2cmf/Comparison/8'&amp;gt;6&amp;lt;/scene&amp;gt; ([[1ut6]]) and &amp;lt;scene name='2cmf/Comparison/9'&amp;gt;7&amp;lt;/scene&amp;gt; ([[1odc]]). The tacrine moieties of these compounds  adopt similar conformations and interactions with CAS as the tacrine in the tacrine/''Tc''AChE, &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE and &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE. Inhibitors '''6''' and '''7''' are spanning the &amp;lt;scene name='2cmf/Comparison/10'&amp;gt;active-site gorge&amp;lt;/scene&amp;gt; between the CAS and the PAS, but since compound '''7''' lacks the second tacrine moiety, Trp279 adopts a different conformation in this complex structure. In the three structures: native ''Tc''AChE (cyan), '''cmp 6'''/''Tc''AChE complex (white), and '''cmp 7'''/''Tc''AChE complex (crimson) ,  all the ''Tc''AChE active-site gorge residues have identical conformation except Trp279 &amp;lt;ref name=&amp;quot;Harel&amp;quot;&amp;gt;PMID:8415649&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;Raves&amp;quot;&amp;gt;PMID:8989325&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;Rydberg&amp;quot;&amp;gt;PMID:16942022&amp;lt;/ref&amp;gt;.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/StructureSection&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1zgb]]  Complex with (''R'')-tacrine-(10)-hupyridone (cmp '''R-3''')&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1zgc]]  Complex with (''S'')-tacrine-(10)-hupyridone (cmp '''S-3''')&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1acj]]  Complex with tacrine alone &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1h22]]  Complex with (S,S)-(-)-''Bis''(12)-hupyridone (cmp '''(S,S)-(-)-4b''')&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1h23]]  Complex with (S,S)-(-)-''Bis''(10)-hupyridone (cmp '''(S,S)-(-)-4a''')&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[2cmf]]  Complex with Bis(5)-tacrine derivative (cmp '''2d''')&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[2ckm]]  Complex with Bis(7)-tacrine derivative (cmp '''2f''')&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1ut6]]  Complex with N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE (cmp '''6''')&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1odc]]  Complex with cmp '''7'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;===Additional Resources===&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;For additional information, see: [[Alzheimer's Disease]] &amp;lt;br /&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''For information about additional AChE inhibitors see page [[AChE bivalent inhibitors (Part II)]].'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;    &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;==References==&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;references/&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: catalytic triad]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: cholinesterase]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: acetylcholinesterase]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: AChE inhibitors and substrates]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: inhibitor]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: cholinesterases]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: acetylcholine]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: cation-pi]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: Alzheimer's]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: nerve gasses]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: ISPC, Israel Structural Proteomics Center.]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: ISPC]]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[[Category: Israel Structural Proteomics Center&lt;/del&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Sun, 08 Mar 2015 10:13:20 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>Alexander Berchansky at 11:26, 20 February 2013</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1723227&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:26, 20 February 2013&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==PART I. Tacrine- and hupyridone-containing compounds==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==PART I. Tacrine- and hupyridone-containing compounds==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''This page is a continuation of the pages [[AChE inhibitors and substrates]], [[AChE inhibitors and substrates (Part II)]], and [[AChE inhibitors and substrates (Part III)]].'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''This page is a continuation of the pages [[AChE inhibitors and substrates]], [[AChE inhibitors and substrates (Part II)]], and [[AChE inhibitors and substrates (Part III)]].'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1zgb]]  Complex with (''R'')-tacrine-(10)-hupyridone (cmp '''R-3''')&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1zgc]]  Complex with (''S'')-tacrine-(10)-hupyridone (cmp '''S-3''')&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1acj]]  Complex with tacrine alone &lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1h22]]  Complex with (S,S)-(-)-''Bis''(12)-hupyridone (cmp '''(S,S)-(-)-4b''')&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1h23]]  Complex with (S,S)-(-)-''Bis''(10)-hupyridone (cmp '''(S,S)-(-)-4a''')&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[2cmf]]  Complex with Bis(5)-tacrine derivative (cmp '''2d''')&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[2ckm]]  Complex with Bis(7)-tacrine derivative (cmp '''2f''')&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1ut6]]  Complex with N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE (cmp '''6''')&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1odc]]  Complex with cmp '''7'''&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' &amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' &amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 36:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 26:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;/StructureSection&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;/StructureSection&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;{{Clear}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1zgb]]  Complex with (''R'')-tacrine-(10)-hupyridone (cmp '''R-3''')&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1zgc]]  Complex with (''S'')-tacrine-(10)-hupyridone (cmp '''S-3''')&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1acj]]  Complex with tacrine alone &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1h22]]  Complex with (S,S)-(-)-''Bis''(12)-hupyridone (cmp '''(S,S)-(-)-4b''')&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1h23]]  Complex with (S,S)-(-)-''Bis''(10)-hupyridone (cmp '''(S,S)-(-)-4a''')&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[2cmf]]  Complex with Bis(5)-tacrine derivative (cmp '''2d''')&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[2ckm]]  Complex with Bis(7)-tacrine derivative (cmp '''2f''')&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1ut6]]  Complex with N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE (cmp '''6''')&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;* [[1odc]]  Complex with cmp '''7'''&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Additional Resources===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Additional Resources===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Wed, 20 Feb 2013 11:26:03 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>Alexander Berchansky at 08:30, 6 December 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1152761&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 08:30, 6 December 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 14:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 14:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' &amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;StructureSection load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' &amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='1zgb/Act_site/3'&amp;gt;active site&amp;lt;/scene&amp;gt; of ''Tc''AChE consists of two binding subsites. First of them is the &amp;quot;catalytic anionic site&amp;quot; (CAS), which involves mentioned above [http://en.wikipedia.org/wiki/Catalytic_triad catalytic triad] &amp;lt;scene name='1zgb/Act_site/8'&amp;gt;Ser200, His440, and Glu327&amp;lt;/scene&amp;gt; &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(colored orange)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and the [http://en.wikipedia.org/wiki/Conserved_sequence#Conserved_protein_sequences_and_Structures conserved residues] &amp;lt;scene name='1zgb/Act_site/5'&amp;gt;Trp84&amp;lt;/scene&amp;gt; and &amp;lt;scene name='1zgb/Act_site/10'&amp;gt;Phe330&amp;lt;/scene&amp;gt; also participating in ligands recognition. Another conserved residue &amp;lt;scene name='1zgb/Act_site/11'&amp;gt;Trp279&amp;lt;/scene&amp;gt; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(colored cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; is situated at the second binding subsite, termed the &amp;quot;peripheral anionic site&amp;quot; (PAS), ~14 Å from CAS. Therefore, the ligands that will be able to interact with both these subsites, will be more potent [http://en.wikipedia.org/wiki/Acetylcholinesterase_inhibitor AChE inhibitors] in comparison to compounds interacting only with CAS. One of the ways to produce such ligands is to introduce two active substances into one compound. If it is spatially necessary these subunits could be divided by alkyl linker with suitable length. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='1zgb/Act_site/3'&amp;gt;active site&amp;lt;/scene&amp;gt; of ''Tc''AChE consists of two binding subsites. First of them is the &amp;quot;catalytic anionic site&amp;quot; (CAS), which involves mentioned above [http://en.wikipedia.org/wiki/Catalytic_triad catalytic triad] &amp;lt;scene name='1zgb/Act_site/8'&amp;gt;Ser200, His440, and Glu327&amp;lt;/scene&amp;gt; &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(colored orange)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and the [http://en.wikipedia.org/wiki/Conserved_sequence#Conserved_protein_sequences_and_Structures conserved residues] &amp;lt;scene name='1zgb/Act_site/5'&amp;gt;Trp84&amp;lt;/scene&amp;gt; and &amp;lt;scene name='1zgb/Act_site/10'&amp;gt;Phe330&amp;lt;/scene&amp;gt; also participating in ligands recognition. Another conserved residue &amp;lt;scene name='1zgb/Act_site/11'&amp;gt;Trp279&amp;lt;/scene&amp;gt; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(colored cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; is situated at the second binding subsite, termed the &amp;quot;peripheral anionic site&amp;quot; (PAS), ~14 Å from CAS. Therefore, the ligands that will be able to interact with both these subsites, will be more potent [http://en.wikipedia.org/wiki/Acetylcholinesterase_inhibitor AChE inhibitors] in comparison to compounds interacting only with CAS. One of the ways to produce such ligands is to introduce two active substances into one compound. If it is spatially necessary these subunits could be divided by alkyl linker with suitable length.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt; &lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;====(''RS'')-(±)-tacrine-(10)-hupyridone====&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;According to the strategy of the use of a bivalent ligand, the &amp;lt;scene name='1zgb/Comp/7'&amp;gt;inhibitor&amp;lt;/scene&amp;gt; '''(''RS'')-(±)-tacrine-(10)-hupyridone''' ((R)-3 or (S)-3) was designed and synthesized. It consists of mentioned in the page '[[AChE inhibitors and substrates]]' &amp;lt;scene name='1zgb/Comp/8'&amp;gt;tacrine&amp;lt;/scene&amp;gt; &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(colored magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, 10-carbon &amp;lt;scene name='1zgb/Comp/9'&amp;gt;linker&amp;lt;/scene&amp;gt; &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt;(yellow)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, and &amp;lt;scene name='1zgb/Comp/10'&amp;gt;hupyridone&amp;lt;/scene&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;(red)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The tacrine moiety of this inhibitor binds at the CAS, the linker spans the &amp;lt;scene name='1zgb/Act_site/12'&amp;gt;active-site&amp;lt;/scene&amp;gt; gorge, and the hupyridone moiety binds at the PAS.    &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;According to the strategy of the use of a bivalent ligand, the &amp;lt;scene name='1zgb/Comp/7'&amp;gt;inhibitor&amp;lt;/scene&amp;gt; '''(''RS'')-(±)-tacrine-(10)-hupyridone''' ((R)-3 or (S)-3) was designed and synthesized. It consists of mentioned in the page '[[AChE inhibitors and substrates]]' &amp;lt;scene name='1zgb/Comp/8'&amp;gt;tacrine&amp;lt;/scene&amp;gt; &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(colored magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, 10-carbon &amp;lt;scene name='1zgb/Comp/9'&amp;gt;linker&amp;lt;/scene&amp;gt; &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt;(yellow)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, and &amp;lt;scene name='1zgb/Comp/10'&amp;gt;hupyridone&amp;lt;/scene&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;(red)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The tacrine moiety of this inhibitor binds at the CAS, the linker spans the &amp;lt;scene name='1zgb/Act_site/12'&amp;gt;active-site&amp;lt;/scene&amp;gt; gorge, and the hupyridone moiety binds at the PAS.    &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with [http://en.wikipedia.org/wiki/Tacrine tacrine] are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the [http://en.wikipedia.org/wiki/Aromaticity aromatic] residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with [http://en.wikipedia.org/wiki/Tacrine tacrine] are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the [http://en.wikipedia.org/wiki/Aromaticity aromatic] residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å) &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt; &lt;/del&gt;.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The &amp;lt;scene name='1zgc/Al/5'&amp;gt;overlap&amp;lt;/scene&amp;gt; of &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 (cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[1zgc]]) bound to the ''Tc''AChE active site in the orthorhombic forms is shown. &amp;lt;scene name='1zgc/Zgc_h22/2'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a (magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3 (orange, orthorhombic ''Tc''AChE)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; demonstrates the similar mode of binding of the hupyridone unit at the PAS. The residues Trp279 (top) and Trp84 (bottom) represent the PAS and the CAS, respectively &amp;lt;ref name=&amp;quot;Haviv&amp;quot;&amp;gt;PMID:16076210&amp;lt;/ref&amp;gt;.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;====Bis-hupyridone====&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE ([[1zgb]]) and bis-hupyridone/''Tc''AChE complexes ([[1h22]] and [[1h23]]) at the &amp;lt;scene name='1zgb/Align2/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. &amp;lt;scene name='1zgb/Align2/8'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(''R'')-tacrine-(10)-hupyridone ((R)-3, cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(12)-hupyridone ('''(S,S)-(-)-4b''', orange, ''i.e.'' 12-carbon-tether-linked hupyridone dimer)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(10)-hupyridone ('''(S,S)-(-)-4a''', plum)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; complexes demonstrates the binding mode of the hupyridone moiety. &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;TcAChE residues of symmetry-related molecule are shown in magenta.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; X-ray structures of ''Tc''AChE complexed with these 10- and 12-carbon-tether-linked 2 &amp;lt;scene name='1zgb/Align2/9'&amp;gt;dimers&amp;lt;/scene&amp;gt; &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; show one subunit bound at the &amp;lt;scene name='1zgb/Align2/10'&amp;gt;CAS&amp;lt;/scene&amp;gt;, the linker spanning the gorge, and the other subunit bound at the &amp;lt;scene name='1zgb/Align2/11'&amp;gt;PAS&amp;lt;/scene&amp;gt;. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE ([[1zgb]]) and bis-hupyridone/''Tc''AChE complexes ([[1h22]] and [[1h23]]) at the &amp;lt;scene name='1zgb/Align2/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. &amp;lt;scene name='1zgb/Align2/8'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(''R'')-tacrine-(10)-hupyridone ((R)-3, cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(12)-hupyridone ('''(S,S)-(-)-4b''', orange, ''i.e.'' 12-carbon-tether-linked hupyridone dimer)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(10)-hupyridone ('''(S,S)-(-)-4a''', plum)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; complexes demonstrates the binding mode of the hupyridone moiety. &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;TcAChE residues of symmetry-related molecule are shown in magenta.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; X-ray structures of ''Tc''AChE complexed with these 10- and 12-carbon-tether-linked 2 &amp;lt;scene name='1zgb/Align2/9'&amp;gt;dimers&amp;lt;/scene&amp;gt; &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; show one subunit bound at the &amp;lt;scene name='1zgb/Align2/10'&amp;gt;CAS&amp;lt;/scene&amp;gt;, the linker spanning the gorge, and the other subunit bound at the &amp;lt;scene name='1zgb/Align2/11'&amp;gt;PAS&amp;lt;/scene&amp;gt;. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;There are two &amp;lt;scene name='1zgb/Align2/12'&amp;gt;hydrogen bonds&amp;lt;/scene&amp;gt; connecting the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;O&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;Lys11&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='blue'&amp;gt;&amp;lt;b&amp;gt;Nζ&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='blue'&amp;gt;&amp;lt;b&amp;gt;N&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;Gln185&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Oε1&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; of a &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;symmetry-related molecule&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE complex. &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; Another hydrogen bond connects the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;O&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to a water molecule, which is bound to Ser286 N. Similarly, the hupyridone-PAS unit of both &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; forms direct and an indirect hydrogen bonds with the protein backbone in the PAS region. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;There are two &amp;lt;scene name='1zgb/Align2/12'&amp;gt;hydrogen bonds&amp;lt;/scene&amp;gt; connecting the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;O&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;Lys11&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='blue'&amp;gt;&amp;lt;b&amp;gt;Nζ&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='blue'&amp;gt;&amp;lt;b&amp;gt;N&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;Gln185&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Oε1&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; of a &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;symmetry-related molecule&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE complex. &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; Another hydrogen bond connects the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;hupyridone&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;O&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; to a water molecule, which is bound to Ser286 N. Similarly, the hupyridone-PAS unit of both &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; forms direct and an indirect hydrogen bonds with the protein backbone in the PAS region &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref name=&amp;quot;Haviv&amp;quot;/&amp;gt; &amp;lt;ref name=&amp;quot;Wong&amp;quot;&amp;gt;PMID:12517147&amp;lt;/ref&amp;gt;&lt;/ins&gt;. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The &amp;lt;scene name&lt;/del&gt;=&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'1zgc/Al/5'&amp;gt;overlap&amp;lt;/scene&amp;gt; of &amp;lt;font color&lt;/del&gt;=&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 (cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color&lt;/del&gt;=&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'orange'&amp;gt;&amp;lt;b&amp;gt;&lt;/del&gt;(&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;S)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[1zgc]]) bound to the &lt;/del&gt;''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;Tc&lt;/del&gt;''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;AChE active site in the orthorhombic forms is shown. &amp;lt;scene name='1zgc/Zgc_h22/2'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(S,S&lt;/del&gt;)-&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(-)-4a (magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color&lt;/del&gt;=&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3 (orange, orthorhombic ''Tc''AChE)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; demonstrates the similar mode of binding of the hupyridone unit at the PAS. The residues Trp279 (top) and Trp84 (bottom) represent the PAS and the CAS, respectively.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;=Bis&lt;/ins&gt;(''&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;n&lt;/ins&gt;'')-&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;tacrine derivatives===&lt;/ins&gt;=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; are bis(''n'')-tacrine derivatives with n=5 and 7 (number of carbons in the linkers), respectively. These compounds are more potent and selective AChE inhibitors than tacrine alone. The binding of the tacrine moiety of &amp;lt;scene name='2cmf/Comparison/2'&amp;gt;2d&amp;lt;/scene&amp;gt; at the ''Tc''AChE catalytic anionic site (CAS) is similar to that of &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;tacrine &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; in the tacrine/''Tc''AChE complex ([[1acj]]). The second tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; interacts with the peripheral anionic site (PAS) near Trp279. The interaction of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS causes an increase of the &amp;lt;scene name='2cmf/Comparison/3'&amp;gt;distance&amp;lt;/scene&amp;gt; between Ser200 Oγ and H440 Nε2 atoms, and, therefore, disruption of the catalytic triad (Ser200, H220, E327) as seen in the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The binding of 2d results in &amp;lt;scene name='2cmf/Comparison/4'&amp;gt;major structural changes&amp;lt;/scene&amp;gt; in the Val281-Ser291 loop  changing the surface of the active-site gorge from its   &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native conformation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The tacrine moiety of the compound &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;'''2f''' (heptylene-linked bis-tacrine&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS, [[2ckm]])  adopts similar &amp;lt;scene name='2cmf/Comparison/5'&amp;gt;conformation&amp;lt;/scene&amp;gt; as tacrine in the tacrine/''Tc''AChE complex and the tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS. The second tacrine moiety of the &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  interacts with PAS near the Trp279, like &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The &amp;lt;scene name='2cmf/Comparison/6'&amp;gt;binding&amp;lt;/scene&amp;gt; of  &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; does not cause significant structural changes in &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;''Tc''AChE&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; from its &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native  structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;.  &amp;lt;scene name='2cmf/Overlap/7'&amp;gt;Comparison&amp;lt;/scene&amp;gt; of the structures of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE  and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE reveals different contacts between the tacrine moieties of these compounds at the PAS and  ''Tc''AChE. There are two additional structures of tacrine-containing ''Tc''AChE complexes: compounds &amp;lt;scene name='2cmf/Comparison/8'&amp;gt;6&amp;lt;/scene&amp;gt; ([[1ut6]]) and &amp;lt;scene name='2cmf/Comparison/9'&amp;gt;7&amp;lt;/scene&amp;gt; ([[1odc]]). The tacrine moieties of these compounds  adopt similar conformations and interactions with CAS as the tacrine in the tacrine/''Tc''AChE, &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE and &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE. Inhibitors '''6''' and '''7''' are spanning the &amp;lt;scene name='2cmf/Comparison/10'&amp;gt;active-site gorge&amp;lt;/scene&amp;gt; between the CAS and the PAS, but since compound '''7''' lacks the second tacrine moiety, Trp279 adopts a different conformation in this complex structure. In the three structures: native ''Tc''AChE (cyan), '''cmp 6'''/''Tc''AChE complex (white), and '''cmp 7'''/''Tc''AChE complex (crimson) ,  all the ''Tc''AChE active-site gorge residues have identical conformation except Trp279 &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref name=&amp;quot;Harel&amp;quot;&amp;gt;PMID:8415649&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;Raves&amp;quot;&amp;gt;PMID:8989325&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;Rydberg&amp;quot;&amp;gt;PMID:16942022&amp;lt;/ref&amp;gt;&lt;/ins&gt;.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;{{Clear}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; are bis(''n'')-tacrine derivatives with n=5 and 7 (number of carbons in the linkers), respectively. These compounds are more potent and selective AChE inhibitors than tacrine alone. The binding of the tacrine moiety of &amp;lt;scene name='2cmf/Comparison/2'&amp;gt;2d&amp;lt;/scene&amp;gt; at the ''Tc''AChE catalytic anionic site (CAS) is similar to that of &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;tacrine &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; in the tacrine/''Tc''AChE complex ([[1acj]]). The second tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; interacts with the peripheral anionic site (PAS) near Trp279. The interaction of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS causes an increase of the &amp;lt;scene name='2cmf/Comparison/3'&amp;gt;distance&amp;lt;/scene&amp;gt; between Ser200 Oγ and H440 Nε2 atoms, and, therefore, disruption of the catalytic triad (Ser200, H220, E327) as seen in the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The binding of 2d results in &amp;lt;scene name='2cmf/Comparison/4'&amp;gt;major structural changes&amp;lt;/scene&amp;gt; in the Val281-Ser291 loop  changing the surface of the active-site gorge from its   &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native conformation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The tacrine moiety of the compound &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;'''2f''' (heptylene-linked bis-tacrine&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS, [[2ckm]])  adopts similar &amp;lt;scene name='2cmf/Comparison/5'&amp;gt;conformation&amp;lt;/scene&amp;gt; as tacrine in the tacrine/''Tc''AChE complex and the tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS. The second tacrine moiety of the &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  interacts with PAS near the Trp279, like &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The &amp;lt;scene name='2cmf/Comparison/6'&amp;gt;binding&amp;lt;/scene&amp;gt; of  &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; does not cause significant structural changes in &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;''Tc''AChE&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; from its &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native  structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;.  &amp;lt;scene name='2cmf/Overlap/7'&amp;gt;Comparison&amp;lt;/scene&amp;gt; of the structures of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE  and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE reveals different contacts between the tacrine moieties of these compounds at the PAS and  ''Tc''AChE. There are two additional structures of tacrine-containing ''Tc''AChE complexes: compounds &amp;lt;scene name='2cmf/Comparison/8'&amp;gt;6&amp;lt;/scene&amp;gt; ([[1ut6]]) and &amp;lt;scene name='2cmf/Comparison/9'&amp;gt;7&amp;lt;/scene&amp;gt; ([[1odc]]). The tacrine moieties of these compounds  adopt similar conformations and interactions with CAS as the tacrine in the tacrine/''Tc''AChE, &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE and &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE. Inhibitors '''6''' and '''7''' are spanning the &amp;lt;scene name='2cmf/Comparison/10'&amp;gt;active-site gorge&amp;lt;/scene&amp;gt; between the CAS and the PAS, but since compound '''7''' lacks the second tacrine moiety, Trp279 adopts a different conformation in this complex structure. In the three structures: native ''Tc''AChE (cyan), '''cmp 6'''/''Tc''AChE complex (white), and '''cmp 7'''/''Tc''AChE complex (crimson) ,  all the ''Tc''AChE active-site gorge residues have identical conformation except Trp279.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;/StructureSection&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;/StructureSection&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 42:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 44:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;    &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;    &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==References==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==References==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;ref group='xtra'&amp;gt;PMID:1678899&amp;lt;/ref&amp;gt; &amp;lt;ref group='xtra'&amp;gt;PMID:15563167&amp;lt;/ref&amp;gt; &amp;lt;ref group='xtra'&amp;gt;PMID:15772291&amp;lt;/ref&amp;gt; &amp;lt;ref group=&amp;quot;xtra&amp;quot;&amp;gt;PMID:16942022&amp;lt;/ref&amp;gt; &lt;/del&gt;&amp;lt;references &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;group='xtra'&lt;/del&gt;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;references/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Category: catalytic triad]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;[[Category: catalytic triad]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 06 Dec 2010 08:30:02 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>Alexander Berchansky at 08:02, 6 December 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1152758&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 08:02, 6 December 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 12:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1odc]]  Complex with cmp '''7'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1odc]]  Complex with cmp '''7'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;applet &lt;/del&gt;load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;/&amp;gt;&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;StructureSection &lt;/ins&gt;load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' &amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;The &amp;lt;scene name='1zgb/Act_site/3'&amp;gt;active site&amp;lt;/scene&amp;gt; of ''Tc''AChE consists of two binding subsites. First of them is the &amp;quot;catalytic anionic site&amp;quot; (CAS), which involves mentioned above [http://en.wikipedia.org/wiki/Catalytic_triad catalytic triad] &amp;lt;scene name='1zgb/Act_site/8'&amp;gt;Ser200, His440, and Glu327&amp;lt;/scene&amp;gt; &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(colored orange)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and the [http://en.wikipedia.org/wiki/Conserved_sequence#Conserved_protein_sequences_and_Structures conserved residues] &amp;lt;scene name='1zgb/Act_site/5'&amp;gt;Trp84&amp;lt;/scene&amp;gt; and &amp;lt;scene name='1zgb/Act_site/10'&amp;gt;Phe330&amp;lt;/scene&amp;gt; also participating in ligands recognition. Another conserved residue &amp;lt;scene name='1zgb/Act_site/11'&amp;gt;Trp279&amp;lt;/scene&amp;gt; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(colored cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; is situated at the second binding subsite, termed the &amp;quot;peripheral anionic site&amp;quot; (PAS), ~14 Å from CAS. Therefore, the ligands that will be able to interact with both these subsites, will be more potent [http://en.wikipedia.org/wiki/Acetylcholinesterase_inhibitor AChE inhibitors] in comparison to compounds interacting only with CAS. One of the ways to produce such ligands is to introduce two active substances into one compound. If it is spatially necessary these subunits could be divided by alkyl linker with suitable length. According to the strategy of the use of a bivalent ligand, the &amp;lt;scene name='1zgb/Comp/7'&amp;gt;inhibitor&amp;lt;/scene&amp;gt; '''(''RS'')-(±)-tacrine-(10)-hupyridone''' ((R)-3 or (S)-3) was designed and synthesized. It consists of mentioned in the page '[[AChE inhibitors and substrates]]' &amp;lt;scene name='1zgb/Comp/8'&amp;gt;tacrine&amp;lt;/scene&amp;gt; &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(colored magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, 10-carbon &amp;lt;scene name='1zgb/Comp/9'&amp;gt;linker&amp;lt;/scene&amp;gt; &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt;(yellow)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, and &amp;lt;scene name='1zgb/Comp/10'&amp;gt;hupyridone&amp;lt;/scene&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;(red)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The tacrine moiety of this inhibitor binds at the CAS, the linker spans the &amp;lt;scene name='1zgb/Act_site/12'&amp;gt;active-site&amp;lt;/scene&amp;gt; gorge, and the hupyridone moiety binds at the PAS.    &lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;{{Clear}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;applet load='ZGBm1.pdb' size='500' frame='true' align='left' scene='1zgb/Align/1' /&lt;/del&gt;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='1zgb/Act_site/3'&amp;gt;active site&amp;lt;/scene&amp;gt; of ''Tc''AChE consists of two binding subsites. First of them is the &amp;quot;catalytic anionic site&amp;quot; (CAS), which involves mentioned above [http://en.wikipedia.org/wiki/Catalytic_triad catalytic triad] &amp;lt;scene name='1zgb/Act_site/8'&amp;gt;Ser200, His440, and Glu327&amp;lt;/scene&amp;gt; &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(colored orange)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and the [http://en.wikipedia.org/wiki/Conserved_sequence#Conserved_protein_sequences_and_Structures conserved residues] &amp;lt;scene name='1zgb/Act_site/5'&amp;gt;Trp84&amp;lt;/scene&amp;gt; and &amp;lt;scene name='1zgb/Act_site/10'&amp;gt;Phe330&amp;lt;/scene&amp;gt; also participating in ligands recognition. Another conserved residue &amp;lt;scene name='1zgb/Act_site/11'&amp;gt;Trp279&amp;lt;/scene&amp;gt; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(colored cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; is situated at the second binding subsite, termed the &amp;quot;peripheral anionic site&amp;quot; (PAS), ~14 Å from CAS. Therefore, the ligands that will be able to interact with both these subsites, will be more potent [http://en.wikipedia.org/wiki/Acetylcholinesterase_inhibitor AChE inhibitors] in comparison to compounds interacting only with CAS. One of the ways to produce such ligands is to introduce two active substances into one compound. If it is spatially necessary these subunits could be divided by alkyl linker with suitable length. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;According to the strategy of the use of a bivalent ligand, the &amp;lt;scene name='1zgb/Comp/7'&amp;gt;inhibitor&amp;lt;/scene&amp;gt; '''(''RS'')-(±)-tacrine-(10)-hupyridone''' ((R)-3 or (S)-3) was designed and synthesized. It consists of mentioned in the page '[[AChE inhibitors and substrates]]' &amp;lt;scene name='1zgb/Comp/8'&amp;gt;tacrine&amp;lt;/scene&amp;gt; &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(colored magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, 10-carbon &amp;lt;scene name='1zgb/Comp/9'&amp;gt;linker&amp;lt;/scene&amp;gt; &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt;(yellow)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, and &amp;lt;scene name='1zgb/Comp/10'&amp;gt;hupyridone&amp;lt;/scene&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;(red)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The tacrine moiety of this inhibitor binds at the CAS, the linker spans the &amp;lt;scene name='1zgb/Act_site/12'&amp;gt;active-site&amp;lt;/scene&amp;gt; gorge, and the hupyridone moiety binds at the PAS.    &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with [http://en.wikipedia.org/wiki/Tacrine tacrine] are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the [http://en.wikipedia.org/wiki/Aromaticity aromatic] residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with [http://en.wikipedia.org/wiki/Tacrine tacrine] are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the [http://en.wikipedia.org/wiki/Aromaticity aromatic] residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å)  .&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å)  .&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGBm5.pdb' size='500' frame='true' align='right' scene='1zgb/Align2/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE ([[1zgb]]) and bis-hupyridone/''Tc''AChE complexes ([[1h22]] and [[1h23]]) at the &amp;lt;scene name='1zgb/Align2/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. &amp;lt;scene name='1zgb/Align2/8'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(''R'')-tacrine-(10)-hupyridone ((R)-3, cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(12)-hupyridone ('''(S,S)-(-)-4b''', orange, ''i.e.'' 12-carbon-tether-linked hupyridone dimer)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(10)-hupyridone ('''(S,S)-(-)-4a''', plum)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; complexes demonstrates the binding mode of the hupyridone moiety. &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;TcAChE residues of symmetry-related molecule are shown in magenta.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; X-ray structures of ''Tc''AChE complexed with these 10- and 12-carbon-tether-linked 2 &amp;lt;scene name='1zgb/Align2/9'&amp;gt;dimers&amp;lt;/scene&amp;gt; &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; show one subunit bound at the &amp;lt;scene name='1zgb/Align2/10'&amp;gt;CAS&amp;lt;/scene&amp;gt;, the linker spanning the gorge, and the other subunit bound at the &amp;lt;scene name='1zgb/Align2/11'&amp;gt;PAS&amp;lt;/scene&amp;gt;. &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE ([[1zgb]]) and bis-hupyridone/''Tc''AChE complexes ([[1h22]] and [[1h23]]) at the &amp;lt;scene name='1zgb/Align2/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. &amp;lt;scene name='1zgb/Align2/8'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(''R'')-tacrine-(10)-hupyridone ((R)-3, cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(12)-hupyridone ('''(S,S)-(-)-4b''', orange, ''i.e.'' 12-carbon-tether-linked hupyridone dimer)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-''Bis''(10)-hupyridone ('''(S,S)-(-)-4a''', plum)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; complexes demonstrates the binding mode of the hupyridone moiety. &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;TcAChE residues of symmetry-related molecule are shown in magenta.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; X-ray structures of ''Tc''AChE complexed with these 10- and 12-carbon-tether-linked 2 &amp;lt;scene name='1zgb/Align2/9'&amp;gt;dimers&amp;lt;/scene&amp;gt; &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4b&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; show one subunit bound at the &amp;lt;scene name='1zgb/Align2/10'&amp;gt;CAS&amp;lt;/scene&amp;gt;, the linker spanning the gorge, and the other subunit bound at the &amp;lt;scene name='1zgb/Align2/11'&amp;gt;PAS&amp;lt;/scene&amp;gt;. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 29:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 25:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGCBm.pdb' size='500' frame='true' align='left' scene='1zgc/Al/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='1zgc/Al/5'&amp;gt;overlap&amp;lt;/scene&amp;gt; of &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 (cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[1zgc]]) bound to the ''Tc''AChE active site in the orthorhombic forms is shown. &amp;lt;scene name='1zgc/Zgc_h22/2'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a (magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3 (orange, orthorhombic ''Tc''AChE)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; demonstrates the similar mode of binding of the hupyridone unit at the PAS. The residues Trp279 (top) and Trp84 (bottom) represent the PAS and the CAS, respectively.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='1zgc/Al/5'&amp;gt;overlap&amp;lt;/scene&amp;gt; of &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 (cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[1zgc]]) bound to the ''Tc''AChE active site in the orthorhombic forms is shown. &amp;lt;scene name='1zgc/Zgc_h22/2'&amp;gt;Superposition&amp;lt;/scene&amp;gt; of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(S,S)-(-)-4a (magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(S)-3 (orange, orthorhombic ''Tc''AChE)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; demonstrates the similar mode of binding of the hupyridone unit at the PAS. The residues Trp279 (top) and Trp84 (bottom) represent the PAS and the CAS, respectively.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 35:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 30:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='2cmf' size='500' frame='true' align='right' &lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;scene='2cmf/Comparison/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; are bis(''n'')-tacrine derivatives with n=5 and 7 (number of carbons in the linkers), respectively. These compounds are more potent and selective AChE inhibitors than tacrine alone. The binding of the tacrine moiety of &amp;lt;scene name='2cmf/Comparison/2'&amp;gt;2d&amp;lt;/scene&amp;gt; at the ''Tc''AChE catalytic anionic site (CAS) is similar to that of &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;tacrine &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; in the tacrine/''Tc''AChE complex ([[1acj]]). The second tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; interacts with the peripheral anionic site (PAS) near Trp279. The interaction of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS causes an increase of the &amp;lt;scene name='2cmf/Comparison/3'&amp;gt;distance&amp;lt;/scene&amp;gt; between Ser200 Oγ and H440 Nε2 atoms, and, therefore, disruption of the catalytic triad (Ser200, H220, E327) as seen in the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The binding of 2d results in &amp;lt;scene name='2cmf/Comparison/4'&amp;gt;major structural changes&amp;lt;/scene&amp;gt; in the Val281-Ser291 loop  changing the surface of the active-site gorge from its   &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native conformation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The tacrine moiety of the compound &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;'''2f''' (heptylene-linked bis-tacrine&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS, [[2ckm]])  adopts similar &amp;lt;scene name='2cmf/Comparison/5'&amp;gt;conformation&amp;lt;/scene&amp;gt; as tacrine in the tacrine/''Tc''AChE complex and the tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS. The second tacrine moiety of the &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  interacts with PAS near the Trp279, like &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The &amp;lt;scene name='2cmf/Comparison/6'&amp;gt;binding&amp;lt;/scene&amp;gt; of  &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; does not cause significant structural changes in &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;''Tc''AChE&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; from its &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native  structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;.  &amp;lt;scene name='2cmf/Overlap/7'&amp;gt;Comparison&amp;lt;/scene&amp;gt; of the structures of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE  and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE reveals different contacts between the tacrine moieties of these compounds at the PAS and  ''Tc''AChE. There are two additional structures of tacrine-containing ''Tc''AChE complexes: compounds &amp;lt;scene name='2cmf/Comparison/8'&amp;gt;6&amp;lt;/scene&amp;gt; ([[1ut6]]) and &amp;lt;scene name='2cmf/Comparison/9'&amp;gt;7&amp;lt;/scene&amp;gt; ([[1odc]]). The tacrine moieties of these compounds  adopt similar conformations and interactions with CAS as the tacrine in the tacrine/''Tc''AChE, &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE and &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE. Inhibitors '''6''' and '''7''' are spanning the &amp;lt;scene name='2cmf/Comparison/10'&amp;gt;active-site gorge&amp;lt;/scene&amp;gt; between the CAS and the PAS, but since compound '''7''' lacks the second tacrine moiety, Trp279 adopts a different conformation in this complex structure. In the three structures: native ''Tc''AChE (cyan), '''cmp 6'''/''Tc''AChE complex (white), and '''cmp 7'''/''Tc''AChE complex (crimson) ,  all the ''Tc''AChE active-site gorge residues have identical conformation except Trp279.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; are bis(''n'')-tacrine derivatives with n=5 and 7 (number of carbons in the linkers), respectively. These compounds are more potent and selective AChE inhibitors than tacrine alone. The binding of the tacrine moiety of &amp;lt;scene name='2cmf/Comparison/2'&amp;gt;2d&amp;lt;/scene&amp;gt; at the ''Tc''AChE catalytic anionic site (CAS) is similar to that of &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;tacrine &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; in the tacrine/''Tc''AChE complex ([[1acj]]). The second tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; interacts with the peripheral anionic site (PAS) near Trp279. The interaction of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS causes an increase of the &amp;lt;scene name='2cmf/Comparison/3'&amp;gt;distance&amp;lt;/scene&amp;gt; between Ser200 Oγ and H440 Nε2 atoms, and, therefore, disruption of the catalytic triad (Ser200, H220, E327) as seen in the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The binding of 2d results in &amp;lt;scene name='2cmf/Comparison/4'&amp;gt;major structural changes&amp;lt;/scene&amp;gt; in the Val281-Ser291 loop  changing the surface of the active-site gorge from its   &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native conformation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The tacrine moiety of the compound &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;'''2f''' (heptylene-linked bis-tacrine&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS, [[2ckm]])  adopts similar &amp;lt;scene name='2cmf/Comparison/5'&amp;gt;conformation&amp;lt;/scene&amp;gt; as tacrine in the tacrine/''Tc''AChE complex and the tacrine moiety of the &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS. The second tacrine moiety of the &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  interacts with PAS near the Trp279, like &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The &amp;lt;scene name='2cmf/Comparison/6'&amp;gt;binding&amp;lt;/scene&amp;gt; of  &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; does not cause significant structural changes in &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;''Tc''AChE&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; from its &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native  structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;.  &amp;lt;scene name='2cmf/Overlap/7'&amp;gt;Comparison&amp;lt;/scene&amp;gt; of the structures of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE  and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE reveals different contacts between the tacrine moieties of these compounds at the PAS and  ''Tc''AChE. There are two additional structures of tacrine-containing ''Tc''AChE complexes: compounds &amp;lt;scene name='2cmf/Comparison/8'&amp;gt;6&amp;lt;/scene&amp;gt; ([[1ut6]]) and &amp;lt;scene name='2cmf/Comparison/9'&amp;gt;7&amp;lt;/scene&amp;gt; ([[1odc]]). The tacrine moieties of these compounds  adopt similar conformations and interactions with CAS as the tacrine in the tacrine/''Tc''AChE, &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE and &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE. Inhibitors '''6''' and '''7''' are spanning the &amp;lt;scene name='2cmf/Comparison/10'&amp;gt;active-site gorge&amp;lt;/scene&amp;gt; between the CAS and the PAS, but since compound '''7''' lacks the second tacrine moiety, Trp279 adopts a different conformation in this complex structure. In the three structures: native ''Tc''AChE (cyan), '''cmp 6'''/''Tc''AChE complex (white), and '''cmp 7'''/''Tc''AChE complex (crimson) ,  all the ''Tc''AChE active-site gorge residues have identical conformation except Trp279.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;/StructureSection&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Mon, 06 Dec 2010 08:02:12 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>David Canner at 09:53, 1 October 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1129192&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 09:53, 1 October 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 41:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 41:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Additional Resources===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Additional Resources===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;For additional information, see: [[Alzheimer's Disease]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;For additional information, see: [[Alzheimer's Disease]] &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;br /&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''For information about additional AChE inhibitors see page [[AChE bivalent inhibitors (Part II)]].'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''For information about additional AChE inhibitors see page [[AChE bivalent inhibitors (Part II)]].'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 01 Oct 2010 09:53:15 GMT</pubDate>			<dc:creator>David Canner</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>David Canner at 09:52, 1 October 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1129191&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 09:52, 1 October 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 40:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;===Additional Resources===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;For additional information, see: [[Alzheimer's Disease]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''For information about additional AChE inhibitors see page [[AChE bivalent inhibitors (Part II)]].'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''For information about additional AChE inhibitors see page [[AChE bivalent inhibitors (Part II)]].'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Fri, 01 Oct 2010 09:52:44 GMT</pubDate>			<dc:creator>David Canner</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>Alexander Berchansky at 11:58, 1 July 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1100210&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:58, 1 July 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==PART I. Tacrine- and hupyridone-containing compounds==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;==PART I. Tacrine- and hupyridone-containing compounds==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''This page is a continuation of the pages [[AChE inhibitors and substrates]] &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;and &lt;/del&gt;[[AChE inhibitors and substrates (Part II)]].'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;'''This page is a continuation of the pages [[AChE inhibitors and substrates]]&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;[[AChE inhibitors and substrates (Part II&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;)]], and [[AChE inhibitors and substrates (Part III&lt;/ins&gt;)]].'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1zgb]]  Complex with (''R'')-tacrine-(10)-hupyridone (cmp '''R-3''')&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;* [[1zgb]]  Complex with (''R'')-tacrine-(10)-hupyridone (cmp '''R-3''')&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 01 Jul 2010 11:58:12 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>Alexander Berchansky at 12:42, 29 April 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1081815&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:42, 29 April 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 37:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 37:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='2cmf' size='500' frame='true' align='right' &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='2cmf' size='500' frame='true' align='right' &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;scene='2cmf/Comparison/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;scene='2cmf/Comparison/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2d&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;and ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2f&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;are bis(''n'')-tacrine derivatives with n=5 and 7 (number of carbons in the linkers), respectively. These compounds are more potent and selective AChE inhibitors than tacrine alone. The binding of the tacrine moiety of &amp;lt;scene name='2cmf/Comparison/2'&amp;gt;2d&amp;lt;/scene&amp;gt; at the ''Tc''AChE catalytic anionic site (CAS) is similar to that of &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;tacrine &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; in the tacrine/''Tc''AChE complex ([[1acj]]). The second tacrine moiety of the ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2d&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;interacts with the peripheral anionic site (PAS) near Trp279. The interaction of ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2d&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;at the CAS causes an increase of the &amp;lt;scene name='2cmf/Comparison/3'&amp;gt;distance&amp;lt;/scene&amp;gt; between Ser200 Oγ and H440 Nε2 atoms, and, therefore, disruption of the catalytic triad (Ser200, H220, E327) as seen in the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The binding of 2d results in &amp;lt;scene name='2cmf/Comparison/4'&amp;gt;major structural changes&amp;lt;/scene&amp;gt; in the Val281-Ser291 loop  changing the surface of the active-site gorge from its   &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native conformation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The tacrine moiety of the compound &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;'''2f''' (heptylene-linked bis-tacrine&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS, [[2ckm]])  adopts similar &amp;lt;scene name='2cmf/Comparison/5'&amp;gt;conformation&amp;lt;/scene&amp;gt; as tacrine in the tacrine/''Tc''AChE complex and the tacrine moiety of the ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2d&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;at the CAS. The second tacrine moiety of the ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2f&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt; interacts with PAS near the Trp279, like ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2d&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;. The &amp;lt;scene name='2cmf/Comparison/6'&amp;gt;binding&amp;lt;/scene&amp;gt; of  ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2f&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;does not cause significant structural changes in &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;''Tc''AChE&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; from its &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native  structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;.  &amp;lt;scene name='2cmf/Overlap/7'&amp;gt;Comparison&amp;lt;/scene&amp;gt; of the structures of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE  and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE reveals different contacts between the tacrine moieties of these compounds at the PAS and  ''Tc''AChE. There are two additional structures of tacrine-containing ''Tc''AChE complexes: compounds &amp;lt;scene name='2cmf/Comparison/8'&amp;gt;6&amp;lt;/scene&amp;gt; ([[1ut6]]) and &amp;lt;scene name='2cmf/Comparison/9'&amp;gt;7&amp;lt;/scene&amp;gt; ([[1odc]]). The tacrine moieties of these compounds  adopt similar conformations and interactions with CAS as the tacrine in the tacrine/''Tc''AChE, ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2f&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;/''Tc''AChE and ''&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'&lt;/del&gt;2d&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;/''Tc''AChE. Inhibitors '''6''' and '''7''' are spanning the &amp;lt;scene name='2cmf/Comparison/10'&amp;gt;active-site gorge&amp;lt;/scene&amp;gt; between the CAS and the PAS, but since compound '''7''' lacks the second tacrine moiety, Trp279 adopts a different conformation in this complex structure. In the three structures: native ''Tc''AChE (cyan), '''cmp 6'''/''Tc''AChE complex (white), and '''cmp 7'''/''Tc''AChE complex (crimson) ,  all the ''Tc''AChE active-site gorge residues have identical conformation except Trp279.&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;magenta&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2d&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &lt;/ins&gt;and &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;orange&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2f&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &lt;/ins&gt;are bis(''n'')-tacrine derivatives with n=5 and 7 (number of carbons in the linkers), respectively. These compounds are more potent and selective AChE inhibitors than tacrine alone. The binding of the tacrine moiety of &amp;lt;scene name='2cmf/Comparison/2'&amp;gt;2d&amp;lt;/scene&amp;gt; at the ''Tc''AChE catalytic anionic site (CAS) is similar to that of &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;tacrine &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; in the tacrine/''Tc''AChE complex ([[1acj]]). The second tacrine moiety of the &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;magenta&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2d&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &lt;/ins&gt;interacts with the peripheral anionic site (PAS) near Trp279. The interaction of &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;magenta&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2d&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &lt;/ins&gt;at the CAS causes an increase of the &amp;lt;scene name='2cmf/Comparison/3'&amp;gt;distance&amp;lt;/scene&amp;gt; between Ser200 Oγ and H440 Nε2 atoms, and, therefore, disruption of the catalytic triad (Ser200, H220, E327) as seen in the &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The binding of 2d results in &amp;lt;scene name='2cmf/Comparison/4'&amp;gt;major structural changes&amp;lt;/scene&amp;gt; in the Val281-Ser291 loop  changing the surface of the active-site gorge from its   &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native conformation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; ([[2ace]]). The tacrine moiety of the compound &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;'''2f''' (heptylene-linked bis-tacrine&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS, [[2ckm]])  adopts similar &amp;lt;scene name='2cmf/Comparison/5'&amp;gt;conformation&amp;lt;/scene&amp;gt; as tacrine in the tacrine/''Tc''AChE complex and the tacrine moiety of the &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;magenta&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2d&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &lt;/ins&gt;at the CAS. The second tacrine moiety of the &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;orange&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2f&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &lt;/ins&gt; interacts with PAS near the Trp279, like &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;magenta&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2d&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;/ins&gt;. The &amp;lt;scene name='2cmf/Comparison/6'&amp;gt;binding&amp;lt;/scene&amp;gt; of  &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;orange&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2f&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; &lt;/ins&gt;does not cause significant structural changes in &amp;lt;font color='plum'&amp;gt;&amp;lt;b&amp;gt;''Tc''AChE&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; from its &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;native  structure&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;.  &amp;lt;scene name='2cmf/Overlap/7'&amp;gt;Comparison&amp;lt;/scene&amp;gt; of the structures of &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;2d&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE  and &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;2f&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;/''Tc''AChE reveals different contacts between the tacrine moieties of these compounds at the PAS and  ''Tc''AChE. There are two additional structures of tacrine-containing ''Tc''AChE complexes: compounds &amp;lt;scene name='2cmf/Comparison/8'&amp;gt;6&amp;lt;/scene&amp;gt; ([[1ut6]]) and &amp;lt;scene name='2cmf/Comparison/9'&amp;gt;7&amp;lt;/scene&amp;gt; ([[1odc]]). The tacrine moieties of these compounds  adopt similar conformations and interactions with CAS as the tacrine in the tacrine/''Tc''AChE, &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;orange&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2f&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;/ins&gt;/''Tc''AChE and &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;font color=&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;magenta&lt;/ins&gt;'&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;&amp;lt;b&amp;gt;&lt;/ins&gt;2d&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;/ins&gt;/''Tc''AChE. Inhibitors '''6''' and '''7''' are spanning the &amp;lt;scene name='2cmf/Comparison/10'&amp;gt;active-site gorge&amp;lt;/scene&amp;gt; between the CAS and the PAS, but since compound '''7''' lacks the second tacrine moiety, Trp279 adopts a different conformation in this complex structure. In the three structures: native ''Tc''AChE (cyan), '''cmp 6'''/''Tc''AChE complex (white), and '''cmp 7'''/''Tc''AChE complex (crimson) ,  all the ''Tc''AChE active-site gorge residues have identical conformation except Trp279.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 29 Apr 2010 12:42:31 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>Alexander Berchansky at 12:51, 4 February 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1043991&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 12:51, 4 February 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 19:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 19:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGBm1.pdb' size='500' frame='true' align='left' scene='1zgb/Align/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGBm1.pdb' size='500' frame='true' align='left' scene='1zgb/Align/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with tacrine are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the aromatic residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[http://en.wikipedia.org/wiki/Tacrine &lt;/ins&gt;tacrine&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;] &lt;/ins&gt;are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[http://en.wikipedia.org/wiki/Aromaticity &lt;/ins&gt;aromatic&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;] &lt;/ins&gt;residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å)  .&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å)  .&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 04 Feb 2010 12:51:01 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
		<item>
			<title>Alexander Berchansky at 11:25, 28 January 2010</title>
			<link>http://52.214.119.220/wiki/index.php?title=AChE_bivalent_inhibitors&amp;diff=1040734&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table style=&quot;background-color: white; color:black;&quot;&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;col class='diff-marker' /&gt;
			&lt;col class='diff-content' /&gt;
			&lt;tr&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;←Older revision&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black;&quot;&gt;Revision as of 11:25, 28 January 2010&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 14:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 14:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGBm.pdb' size='500' frame='true' align='right' scene='1zgb/Com_view/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='1zgb/Act_site/3'&amp;gt;active site&amp;lt;/scene&amp;gt; of ''Tc''AChE consists of two binding subsites. First of them is the &amp;quot;catalytic anionic site&amp;quot; (CAS), which involves mentioned above catalytic triad &amp;lt;scene name='1zgb/Act_site/8'&amp;gt;Ser200, His440, and Glu327&amp;lt;/scene&amp;gt; &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(colored orange)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and the conserved residues &amp;lt;scene name='1zgb/Act_site/5'&amp;gt;Trp84&amp;lt;/scene&amp;gt; and &amp;lt;scene name='1zgb/Act_site/10'&amp;gt;Phe330&amp;lt;/scene&amp;gt; also participating in ligands recognition. Another conserved residue &amp;lt;scene name='1zgb/Act_site/11'&amp;gt;Trp279&amp;lt;/scene&amp;gt; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(colored cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; is situated at the second binding subsite, termed the &amp;quot;peripheral anionic site&amp;quot; (PAS), ~14 Å from CAS. Therefore, the ligands that will be able to interact with both these subsites, will be more potent AChE inhibitors in comparison to compounds interacting only with CAS. One of the ways to produce such ligands is to introduce two active substances into one compound. If it is spatially necessary these subunits could be divided by alkyl linker with suitable length. According to the strategy of the use of a bivalent ligand, the &amp;lt;scene name='1zgb/Comp/7'&amp;gt;inhibitor&amp;lt;/scene&amp;gt; '''(''RS'')-(±)-tacrine-(10)-hupyridone''' ((R)-3 or (S)-3) was designed and synthesized. It consists of mentioned in the page '[[AChE inhibitors and substrates]]' &amp;lt;scene name='1zgb/Comp/8'&amp;gt;tacrine&amp;lt;/scene&amp;gt; &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(colored magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, 10-carbon &amp;lt;scene name='1zgb/Comp/9'&amp;gt;linker&amp;lt;/scene&amp;gt; &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt;(yellow)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, and &amp;lt;scene name='1zgb/Comp/10'&amp;gt;hupyridone&amp;lt;/scene&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;(red)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The tacrine moiety of this inhibitor binds at the CAS, the linker spans the &amp;lt;scene name='1zgb/Act_site/12'&amp;gt;active-site&amp;lt;/scene&amp;gt; gorge, and the hupyridone moiety binds at the PAS.    &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The &amp;lt;scene name='1zgb/Act_site/3'&amp;gt;active site&amp;lt;/scene&amp;gt; of ''Tc''AChE consists of two binding subsites. First of them is the &amp;quot;catalytic anionic site&amp;quot; (CAS), which involves mentioned above &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[http://en.wikipedia.org/wiki/Catalytic_triad &lt;/ins&gt;catalytic triad&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;] &lt;/ins&gt;&amp;lt;scene name='1zgb/Act_site/8'&amp;gt;Ser200, His440, and Glu327&amp;lt;/scene&amp;gt; &amp;lt;font color='orange'&amp;gt;&amp;lt;b&amp;gt;(colored orange)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and the &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[http://en.wikipedia.org/wiki/Conserved_sequence#Conserved_protein_sequences_and_Structures &lt;/ins&gt;conserved residues&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;] &lt;/ins&gt;&amp;lt;scene name='1zgb/Act_site/5'&amp;gt;Trp84&amp;lt;/scene&amp;gt; and &amp;lt;scene name='1zgb/Act_site/10'&amp;gt;Phe330&amp;lt;/scene&amp;gt; also participating in ligands recognition. Another conserved residue &amp;lt;scene name='1zgb/Act_site/11'&amp;gt;Trp279&amp;lt;/scene&amp;gt; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(colored cyan)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; is situated at the second binding subsite, termed the &amp;quot;peripheral anionic site&amp;quot; (PAS), ~14 Å from CAS. Therefore, the ligands that will be able to interact with both these subsites, will be more potent &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;[http://en.wikipedia.org/wiki/Acetylcholinesterase_inhibitor &lt;/ins&gt;AChE inhibitors&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;] &lt;/ins&gt;in comparison to compounds interacting only with CAS. One of the ways to produce such ligands is to introduce two active substances into one compound. If it is spatially necessary these subunits could be divided by alkyl linker with suitable length. According to the strategy of the use of a bivalent ligand, the &amp;lt;scene name='1zgb/Comp/7'&amp;gt;inhibitor&amp;lt;/scene&amp;gt; '''(''RS'')-(±)-tacrine-(10)-hupyridone''' ((R)-3 or (S)-3) was designed and synthesized. It consists of mentioned in the page '[[AChE inhibitors and substrates]]' &amp;lt;scene name='1zgb/Comp/8'&amp;gt;tacrine&amp;lt;/scene&amp;gt; &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;(colored magenta)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, 10-carbon &amp;lt;scene name='1zgb/Comp/9'&amp;gt;linker&amp;lt;/scene&amp;gt; &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt;(yellow)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;, and &amp;lt;scene name='1zgb/Comp/10'&amp;gt;hupyridone&amp;lt;/scene&amp;gt; &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;(red)&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;. The tacrine moiety of this inhibitor binds at the CAS, the linker spans the &amp;lt;scene name='1zgb/Act_site/12'&amp;gt;active-site&amp;lt;/scene&amp;gt; gorge, and the hupyridone moiety binds at the PAS.    &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGBm1.pdb' size='500' frame='true' align='left' scene='1zgb/Align/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;&amp;lt;applet load='ZGBm1.pdb' size='500' frame='true' align='left' scene='1zgb/Align/1' /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;(&lt;/del&gt;&amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with tacrine are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the aromatic residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The comparison of the (R)-3/''Tc''AChE and tacrine/''Tc''AChE complexes at the &amp;lt;scene name='1zgb/Align/2'&amp;gt;active site&amp;lt;/scene&amp;gt;. A &amp;lt;scene name='1zgb/Align/7'&amp;gt;comparison&amp;lt;/scene&amp;gt; of the trigonal (R)-3/''Tc''AChE structure ([[1zgb]]; &amp;lt;font color='cyan'&amp;gt;&amp;lt;b&amp;gt;(R)-3 colored cyan&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; ''Tc''AChE residues interacting with (R)-3 are colored sea-green) with the crystal structure of tacrine/''Tc''AChE ([[1acj]], &amp;lt;font color='magenta'&amp;gt;&amp;lt;b&amp;gt;tacrine colored magenta&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;; residues interacting with tacrine are colored &amp;lt;font color='pink'&amp;gt;&amp;lt;b&amp;gt;pink&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;) reveals a similar binding mode for the tacrine moiety. In both structures the tacrine ring is situated at the CAS, between the aromatic residues Trp84 and Phe330. Steric clash with the 10-carbon linker could explain the tilt observed for the Phe330 &amp;lt;font color='yellow'&amp;gt;&amp;lt;b&amp;gt; (yellow&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; and transparent in the tacrine/''Tc''AChE). &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;Water molecules are shown as red spheres.&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å)  .&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;The tacrine unit of (R)-3 N forms &amp;lt;scene name='1zgb/Align/8'&amp;gt;hydrogen bond&amp;lt;/scene&amp;gt; with His440 O (3.0 Å) similar to that of tacrine alone. Similarly to the tacrine/''Tc''AChE structure the &amp;lt;font color='red'&amp;gt;&amp;lt;b&amp;gt;system of three water molecules&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt; at the CAS ((R)-3/''Tc''AChE) binds the tacrine-linker N via hydrogen bonds to Ser81 O, Ser122 Oγ, and Asn85 Oδ1 (2.6-3.5 Å)  .&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; color:black; font-size: smaller;&quot;&gt;&lt;div&gt;{{Clear}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Thu, 28 Jan 2010 11:25:41 GMT</pubDate>			<dc:creator>Alexander Berchansky</dc:creator>			<comments>http://52.214.119.220/wiki/index.php/Talk:AChE_bivalent_inhibitors</comments>		</item>
	</channel>
</rss>